CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-28 | Porter Andy Chief Administrative Officer | Sale | −448 | $21.54 | $10K | 45,164 |
| 2022-10-28 | Catinazzo Thomas Chief Financial Officer | Sale | −1,099 | $21.54 | $24K | 50,676 |
| 2022-10-28 | Bergstrom Donald A President, R&D | Sale | −1,817 | $21.54 | $39K | 86,866 |
| 2022-10-28 | Adams Brian Chief Legal Officer | Sale | −728 | $21.54 | $16K | 61,820 |
| 2022-10-13 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 268,554 |
| 2022-10-13 | Patel Sanjiv President and CEO | Sale | −14,000 | $20.58 | $288K | 254,554 |
| 2022-10-13 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 32,175 | ||
| 2022-10-12 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 268,554 |
| 2022-10-12 | Patel Sanjiv President and CEO | Sale | −14,000 | $21.18 | $297K | 254,554 |
| 2022-10-12 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 46,175 | ||
| 2022-10-11 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 268,554 |
| 2022-10-11 | Patel Sanjiv President and CEO | Sale | −14,000 | $21.36 | $299K | 254,554 |
| 2022-10-11 | Patel Sanjiv President and CEO | Option exercise · Stock Option (Right to Buy) | −14,000 | 60,175 | ||
| 2022-10-03 | Bergstrom Donald A President, R&D | Option exercise | +8,000 | $4.12 | $33K | 96,683 |
| 2022-10-03 | Bergstrom Donald A President, R&D | Sale | −8,000 | $22.43 | $179K | 88,683 |
| 2022-10-03 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −8,000 | 101,456 | ||
| 2022-09-27 | Porter Andy Chief Administrative Officer | Sale | −259 | $22.73 | $6K | 45,612 |
| 2022-09-27 | Catinazzo Thomas Chief Financial Officer | Sale | −443 | $22.73 | $10K | 51,775 |
| 2022-09-27 | Bergstrom Donald A President, R&D | Sale | −976 | $22.73 | $22K | 88,683 |
| 2022-09-27 | Adams Brian Chief Legal Officer | Sale | −294 | $22.73 | $7K | 62,548 |
Page 16 of 17 · 329 trades